Clinical Trial Update: Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis

View source ↗

Summary

A clinical trial update evaluating the effects and cost-effectiveness of early antiviral therapy for HBV-related compensated liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis

Drugs mentioned

• HBV antiviral therapy

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Liver Cirrhosis, Hepatitis B | Status: UNKNOWN